Infant formula recall
This article was originally published in The Tan Sheet
Executive Summary
Mead Johnson is issuing a recall of 41,464 GENTLEASE powdered infant formula cans due to contamination with metal particles up to 2.7 mm in size, FDA announces Feb. 22. Though no injuries have been reported to date, the particles could damage an infant's respiratory system and throat if inhaled into the lungs. Damage to the throat may cause coughing, difficulty swallowing or difficulty breathing, according to FDA, while similar damage to the lungs could provoke coughing and difficulty breathing. The 24-ounce cans were distributed through major retail stores across the country beginning Dec. 16, 2005. The recalled lot is identified by number BMJ19 and an expiration/use-by date of 1 Jul 07 embossed on the bottom of the can...
You may also be interested in...
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.
Beauty Firms Using AI-Based Tools Could Be Subject To Health Privacy Laws In US States
Using AI-based programs to collect and store consumer information risks running afoul of new health privacy laws cropping up in US states. Lack of federal regulation or guidance on the issue is one of the biggest challenges for beauty firms deploying AI, according to Stacy Marcus, partner at Reed Smith LLP.